ResearcherIndiana University IndianapolisNo recent work listed

Neelakanta Dadi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5088187633. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2017: 1 paper

Papers 1

Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. Co-author DOI 10.21873/anticanres.11985 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Amikar Sehdev · 1 shared paper, 2017 · strength 0.09
- Paper Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. DOI 10.21873/anticanres.11985 ↗
Safi Shahda · 1 shared paper, 2017 · strength 0.09
- Paper Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. DOI 10.21873/anticanres.11985 ↗
Bert H. O’Neil · 1 shared paper, 2017 · strength 0.09
- Paper Impact of Nab-Paclitaxel-based Second-line Chemotherapy in Metastatic Pancreatic Cancer. DOI 10.21873/anticanres.11985 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.